Nebenwirkungen · CellCept
CellCept 1 g/5 ml powder for oral suspension · Abschnitt 4.8 · PDF-Seite 54
HOS-085350 · Präparat HOS-083095
(MedDRA) Renal Hepatic Cardiac transplant transplant transplant System Organ Class Frequency Frequency Frequency Infections and infestations Bacterial infections Very Common Very Common Very Common Fungal infections Common Very Common Very Common Protozoal infections Uncommon Uncommon Uncommon Viral infections Very Common Very Common Very Common Neoplasms benign, malignant and unspecified (including cysts and polyps) Benign neoplasm of skin Common Common Common Lymphoma Uncommon Uncommon Uncommon Lymphoproliferative disorder Uncommon Uncommon Uncommon Neoplasm Common Common Common Skin cancer Common Uncommon Common Blood and lymphatic system disorders Anaemia Very Common Very Common Very Common Aplasia pure red cell Uncommon Uncommon Uncommon Bone marrow failure Uncommon Uncommon Uncommon Ecchymosis Common Common Very Common Leukocytosis Common Very Common Very Common Leukopenia Very Common Very Common Very Common Pancytopenia Common Common Uncommon Pseudolymphoma Uncommon Uncommon Common Thrombocytopenia Common Very Common Very Common Metabolism and nutrition disorders Acidosis Common Common Very Common Hypercholesterolaemia Very Common Common Very Common Hyperglycaemia Common Very Common Very Common Hyperkalaemia Common Very Common Very Common Hyperlipidaemia Common Common Very Common Hypocalcaemia Common Very Common Common Hypokalaemia Common Very Common Very Common Hypomagnesaemia Common Very Common Very Common Hypophosphataemia Very Common Very Common Common Hyperuricaemia Common Common Very Common Gout Common Common Very Common Weight decreased Common Common Common Psychiatric disorders Confusional state Common Very Common Very Common Depression Common Very Common Very Common Insomnia Common Very Common Very Common Agitation Uncommon Common Very Common
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-07T14:22:00Z · SHA-256 8464b0a5294445d85b3f9b902633989ca6f57af3990241a80eda4979936ba419 · Passage 6ca81d927dfa782d219e0e313caad05bdf7b3bc76c0ffeff7156f39cd060c50c · Zeichen 1370–4685 im Abschnitt